SEMINAR: Identification of Therapeutic and Diagnostic Targets During Progression of Human Papillomavirus-Associated Cancers

Dr. Joongho Joh
When Sep 28, 2017
from 12:00 PM to 01:30 PM
Where Vogt Bldg, Rm 311
Contact Name
Contact Phone 502-852-7485
Add event to calendarvCal

Abstract: Human papillomaviruses (HPV) are the most common sexually transmitted pathogens world-wide, with 10% of infections persisting and approximately 1% progressing to cervical cancer. In addition to cervical cancer, persistence of HPV infection has recently been linked to other cancers, particularly of the skin as well as head and neck cancers. Our laboratory isolated the first mouse papillomavirus, MmuPV1, and we have established a laboratory mouse model for HPV-induced cancer development. By utilizing the model, we identified various cellular molecules as the therapeutic and diagnostic targets for human Papillomavirus-associated cancers.

Speaker:  Dr. Joongho Joh obtained his Ph. D. at Konkuk University in South Korea in Biochemistry and Microbiology, and did postdoctoral work in Biomedical Chemistry in South Korea and Cancer Virology and Vaccinology at the University of Louisville. He was recently appointed as Assistant Professor in the Department of Medicine, where the focus of his work is to establish precision medicine models for HPV-associated HNC patients with different risk factors and molecular markers for different stages of cancers.

YouTube Video of the seminar